Cardiac Marker Testing Devices are tools are designed to give a quick glimpse into the heart's health, which can help prevent potentially life-threatening complications. These tests are inexpensive, easy to learn, and can be used anywhere.
Using a point-of-care testing device, a rapid diagnosis can be made in a matter of minutes. The results can rule out acute myocardial infarction (AMI) in a safe and effective manner. This can help reduce unnecessary transfers to secondary hospitals and save lives. The test measures cardiac troponin T and I in the bloodstream. The presence of small amounts of these biomarkers can indicate injury to heart muscles. The test is most commonly used to assess patients with chest pain or other symptoms of heart damage. Depending on the type of test, a patient may be tested once or twice over six to twenty-four hours. The test is usually performed in a hospital setting. A blood sample is taken from the arm. The results are reported using a reference range. Healthcare providers have begun using Myoglobin and Cardiac Marker Testing Devices to detect heart attacks in recent years. These tests are often performed in a phlebotomist, who draws the blood sample. A healthcare provider usually sends the blood sample to a laboratory. Myoglobin is a protein present in the skeletal muscle and in the heart. It is also one of the first biomarkers to rise in the blood after a heart attack. However, it does not necessarily indicate that the patient has a heart attack. Elevated levels can be a sign of trauma, muscle injury, or crushing injuries. Cardiac Marker Testing Devices are vital tools whether it's identifying a heart attack or determining the likelihood of cardiovascular disease. These tests detect endogenous substances released from the blood during circulation. These markers can be used to assess a patient's risk of cardiovascular disease and assess future treatment. The Minicare I-20 handheld diagnostics platform, launched by Royal Philips in May 2016, enables rapid diagnosis of acute heart attack. The device provides clinical information from a finger prick of blood. It features application-specific cartridges, single-use disposable cartridges, a hand-held analyzer and software. The system is based on proprietary biosensor technology. The Minicare I-20 can also test for viral infections, brain injury, and cardiac injury along with testing for cardiac troponin. The device offers on-the-spot results, which simplify the interaction between physicians and patients. The device can be easily used by non-laboratory staff, and data can be automatically updated into hospital information systems. Developed by Siemens Healthineers, the Atellica VTLi Cardiac Marker Testing Devices offers a quick point-of-care test for heart attack patients. This analyzer can help reduce strain on overcrowded EDs. Using a finger stick blood sample, the analyzer provides accurate and reliable results. It can also be used for early detection of cardiovascular diseases. The Atellica VTLi is powered by Magnotech Technology, which offers improved operational efficiency. It also helps accelerate care and reduce turnaround time. Moreover, the analyzer's wireless capability allows it to be easily integrated with the POC Ecosystem Solution from Siemens Healthineers. This system allows clinicians to easily connect to laboratory information systems. It also has a centralized control over point-of-care testing.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2023
Categories
All
|